Strategic research cooperation between BiondVax and Max Planck and UMG:…
JERUSALEM, September 20, 2022 /PRNewswire/ — BiondVax Pharmaceuticals Ltd. BVXV, which focuses on the development, manufacturing and marketing of innovative products for the prevention and